Skip to content
FDA drug shortage status

Is Sodium Bicarbonate Injection in shortage?

Yes. Sodium Bicarbonate Injection is on FDA’s drug shortage list (unavailable), last updated Nov 18, 2026.

In shortageFDA status
11packages listed
1unavailable

Why it’s in shortage

  • Demand increase for the drug
  • Other

Every listed package

FDA tracks shortages per package. What each maker reports, most recently updated first:

  • Sodium Bicarbonate, Injection, 42 mg/1 mL (NDC 63323-083-05)
    Fresenius Kabi USA, LLCIn shortageAvailableUpdated Nov 18, 2026

    Check wholesalers for inventory.

    Maker contact: 888-386-1300

  • Sodium Bicarbonate, Injection, 84 mg/1 mL (NDC 63323-089-50)
    Fresenius Kabi USA, LLCIn shortageAvailableUpdated Nov 18, 2026

    Check wholesalers for inventory

    Maker contact: 888-386-1300

  • Sodium Bicarbonate, Injection, 84 mg/1 mL (NDC 81298-7620-3)
    Long Grove Pharmaceuticals LLCIn shortageAvailableUpdated Nov 16, 2026

    Maker contact: 833-268-5559

  • Sodium Bicarbonate, Injection, 2.5 mEq/5 mL (4.2%, 0.5 mEq/mL) (NDC 0409-5555-01)
    Hospira, Inc., a Pfizer CompanyIn shortageLimited AvailabilityUpdated Nov 9, 2026

    Limited Supply Available. Next Delivery: July 2027; Estimated Recovery: September 2027; Shortage per Manufacturer: Manufacturing Delay

    Maker contact: 844-646-4398

  • Sodium Bicarbonate, Injection, 2.5 mEq/5 mL (4.2%, 0.5 mEq/mL) (NDC 0409-5555-02)
    Hospira, Inc., a Pfizer CompanyIn shortageLimited AvailabilityUpdated Nov 9, 2026

    Limited Supply Available. Next Delivery: February 2027; Estimated Recovery: March 2027

    Maker contact: 844-646-4398

  • Sodium Bicarbonate, Injection, 50 mEq/50 mL (8.4%, 1 mEq/mL) (NDC 0409-6625-14)
    Hospira, Inc., a Pfizer CompanyIn shortageAvailableUpdated Nov 9, 2026

    Maker contact: 844-646-4398

  • Sodium Bicarbonate, Injection, 50 mEq/50 mL (8.4%, 1 mEq/mL) (NDC 0409-6625-35)
    Hospira, Inc., a Pfizer CompanyIn shortageUnavailableUpdated Nov 9, 2026

    Next Delivery and Estimated Recovery: June 2027; Shortage per Manufacturer: Manufacturing Delay

    Maker contact: 844-646-4398

  • Sodium Bicarbonate, Injection, 84 mg/1 mL (NDC 76329-3352-1)
    Amphastar Pharmaceuticals, Inc.In shortageLimited AvailabilityUpdated Nov 6, 2026

    Available on allocation

    Maker contact: 800-423-4136

  • Sodium Bicarbonate, Injection, 84 mg/1 mL (NDC 51754-5001-5)
    Exela Pharma Sciences, LLCIn shortageAvailableUpdated Oct 15, 2026

    Maker contact: 828-758-5474 ext. 154

  • Sodium Bicarbonate, Injection, 84 mg/1 mL (NDC 51754-5011-4)
    Exela Pharma Sciences, LLCIn shortageAvailableUpdated Oct 15, 2026

    Maker contact: 828-758-5474 ext. 154

  • Sodium Bicarbonate, Injection, 42 mg/1 mL (NDC 51754-5012-4)
    Exela Pharma Sciences, LLCIn shortageAvailableUpdated Oct 15, 2026

    Maker contact: 828-758-5474 ext. 154

No longer on FDA’s list (4)

These packages were on FDA’s shortage list and have since been removed (last seen Nov 9, 2026). Removal usually means supply recovered.

  • Sodium Bicarbonate, Injection, 84 mg/1 mL (NDC 0409-4900-14)
  • Sodium Bicarbonate, Injection, 75 mg/1 mL (NDC 0409-4916-14)
  • Sodium Bicarbonate, Injection, 42 mg/1 mL (NDC 0409-5534-14)
  • Sodium Bicarbonate, Injection, 84 mg/1 mL (NDC 0409-6637-14)

FDA recalls of Sodium Bicarbonate

Recalls can cause or worsen a shortage. These FDA drug recalls share an active ingredient with Sodium Bicarbonate Injection:

Sodium Bicarbonate Injection shortage questions

Is Sodium Bicarbonate Injection in shortage?

Yes. Sodium Bicarbonate Injection is on FDA’s drug shortage list (unavailable), last updated Nov 18, 2026.

Why is there a Sodium Bicarbonate Injection shortage?

FDA records the reason as: Demand increase for the drug; Other.

What should I do if I can’t get Sodium Bicarbonate Injection?

Don’t stop or ration it on your own. Ask your pharmacist whether another strength, package size or maker is in stock, and ask your prescriber about an alternative if none is.

Source: FDA Drug Shortages Database via openFDA. FDA notes that openFDA data is unvalidated and should not be used to make decisions about medical care; ask your pharmacist or prescriber before changing any medication. FDA Drug Shortages Database.